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Purpose: To compare moderate and advanced glaucoma patients in Ghana.
Methods: A retrospective cross-sectional study of 164 patients with primary open-angle 
glaucoma (POAG) were separated into moderate and advanced glaucoma groups. Definitions of 
moderate and advanced POAG were derived from International Geographical and Epidemiologic 
Ophthalmology criteria and included clinical assessment of optic disc atrophy and Humphrey 
automated perimetry. Data were collected at the patient’s first visit prior to initiation of therapy. 
Eligible POAG patients included those $30 years old with reliable Humphrey visual field (HVF) 
results, no past POAG diagnosis, treatment, or evidence of a secondary cause for glaucoma. 
Main outcome measures included comparisons of intraocular pressure (IOP), cup-to-disk ratio 
(CDR), best corrected visual acuity (VA), age, Humphrey mean deviation (MD), and pattern 
standard deviation (PSD).
Results: Of 164 charts reviewed, 90 (54.9%) advanced and 74 (45.1%) moderate POAG patients 
were compared. Mean age was 59.36 versus 55.53 years, respectively. Significant differences in 
IOP, CDR, CDR asymmetry, and HVF results were described. IOP . 30 mmHg was associated 
with CDR . 0.7 and MD greater than −12 dB in both eyes.
Conclusion: Significant differences were found between IOP, CDR, MD and PSD values. HVF 
is predictive of pretreated IOP, CDR, and severity of POAG and it is strongly encouraged as 
part of the standard glaucoma work up in all Ghanaian patients.
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Introduction
Primary open-angle glaucoma (POAG) is the leading cause of irreversible   blindness 
worldwide.1 The number of persons affected is estimated to be in the region of 
66.8 million with 6.7 million blind.2 This disorder is characterized by progressive optic 
neuropathy eventually leading to loss of central vision and total blindness in its final 
stages. A population study in Ghana reported that POAG affects 7.7% and 8.5% of 
people 30 and 40 years of age, respectively3 whereas 1.9% of Americans over 40 years 
of age are reported affected.4
Established risk factors for POAG in Ghanaian patients include elevated intraocu-
lar pressure (IOP), a family history, old age, and African ancestry.3 Recent studies in 
Ghana have also identified late presentation and a delay in diagnosis as significant risk 
factors.5,6 Treatment consists of lowering the IOP through medical or surgical   methods.7 
As of 2004, there are 45 ophthalmologists practicing in Ghana, or approximately 
one per 500,000 persons.8 The majority of these physicians practice in the outpatient 
setting near the capital city of Accra. Patients in this practice setting are the focus of 
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This study aims to describe and compare two POAG 
patient groups at separate stages of disease severity for asso-
ciations between clinical findings including IOP, cup-to-disk 
ratio (CDR), CDR asymmetry, age, visual acuity (VA) and 
Humphrey visual field (HVF) mean deviation (MD), and 
pattern standard deviation (PSD).
Methods
This was a retrospective cross-sectional study involving 
164 patient charts reviewed at the Emmanuel Eye Clinic, 
a large outpatient eye clinic in Accra, Ghana with an annual 
volume that exceeds 30,000 patients. Data were gathered 
from the patients’ initial visits prior to initiation of medical 
therapy.
inclusion criteria
Two broad patient groups were formed and defined according 
to modified International Geographical and Epidemiologic 
  Ophthalmology (ISGEO) POAG criteria (Table 1).9 The first 
group was defined as having moderate glaucoma, with clinical 
  findings showing disk cupping (CDR 0.7–0.8) without a visual 
field defect (VFD) or a CDR , 0.7 with a confirmed VFD. 
The second group was defined as having advanced glaucoma, 
with clinical findings showing either advanced structural 
and functional damage (CDR . 0.7 with a confirmed VFD) 
or advanced optic nerve atrophy (CDR . 0.9) with or 
without satisfactory HVF results. Eligible patients included 
those $30 years old with a diagnosis of POAG on record, 
no past diagnosis or treatment for glaucoma or ocular hyper-
tension elsewhere and no history or clinical evidence for 
a secondary or congenital cause of glaucoma.
All patients had received at the initial visit a comprehensive 
slit-lamp examination, Goldmann applanation tonometry 
(Haag-Streit, Mason, OH), gonioscopy, and 24-2 HVF at their 
initial presentation. Only reliable HVF results were included 
in this study. We chose to base a patient’s IOP on the   average 
of two consecutive measurements taken from the patient chart 
prior to initiation of any medical therapy.
Main outcome measures
Patient groups were described and compared.   Comparisons 
include  age,  gender,  IOP,  CDR,  CDR  asymmetry, 
HVF MD/PSD values and VA results. All VA data were 
recorded from a standard Snellen chart at 20 feet (6 m) and 
converted to logMAR format for standardized comparisons. 
Associations were derived using odds ratio (OR)   comparisons. 
The moderate group functioned as the control.
Definitions
A VFD was determined by Humphrey computer-based 
automated perimetry, meaning positive results of hemi-
meridional analyses of threshold tests and/or the presence 
of one or more absolute defects in the central 30° as tested 
with the full threshold strategy 24-2 (central 54 points, two 
zone strategy) with ophthalmologic interpretation used for 
definitive diagnosis of glaucomatous field loss. 
Exclusion criteria
Secondary or congenital causes of glaucoma were excluded 
from this study. Patients with prior trabeculectomy or medi-
cally controlled IOPs were excluded. A retinal disease that 
may cause visual field defects or macular disease which sig-
nificantly impairs central vision was an exclusion criterion. 
Patients with closed angles on gonioscopy were diagnosed 
as angle closure glaucoma and excluded.
Data analysis
For one eye’s data analysis (oculus dexter [OD] or oculus 
sinister [OS]), the two-sample t-test was applied to compare 
mean age, IOP, CDR, CDR asymmetry, MD/PSD and VA 
in logMAR between groups. Ordinal logistic regression 
was used in the comparison of VA when it was treated 
as ordinal data. For both eyes’ data combined, the mixed 
model was used to account for between-eye correlations. 
The mixed model was also applied to assess correlations 
between MD and other risk factors when treating them as 
continuous variables. The associations of age $65 years and 
IOP (worse IOP of two eyes $31 mmHg) with advanced 
glaucoma were assessed by calculating ORs via logistic 
Table 1 Definitions of moderate and advanced primary open-
angle glaucoma used in this study
Advanced POAG group
Category 1: a definite and reliable glaucomatous visual field defect was 
found in the presence of either CDr $ 0.7 or a CDr asymmetry $0.2 
between adjacent eyes
Category 2: Humphrey 24-2 visual field testing was not completed 
satisfactorily, but the CDr was $0.9, or CDr asymmetry was $0.3
Moderate POAG group
CDr 0.7 or 0.8 without   VFD; category 1, but not category 2, optic disc 
criteria met, but were not proven to have reliable or definite visual field 
defects
CDr , 0.7 with a definitive VFD; Those with definitive visual field 
defects, but not meeting category 1 disc criteria or those with optic disc 
margin hemorrhages
Note: Advanced and moderate glaucoma definitions were modified from International 
Geographical  and  Epidemiologic  Ophthalmology  classifications  first  published  by 
Foster P, et al.9
Abbreviations:  POAG,  primary  open-angle  glaucoma;  CDR,  cup-to-disk  ratio; 
VFD, visual field defect.
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regression models. Gender distribution difference between 
groups was done by the Chi-square test. The comparison of 
risk factors across groups defined by MD values was done 
using analysis of variance.
Results
Basic demographics of moderate and advanced POAG groups 
are shown in Table 2. Of 164 charts included, 90 (54.9%) 
were advanced POAG patients and 74 (45.1%) were 
  moderate POAG patients. The mean age for all patients was 
57.66 years with a standard deviation of 15.03 years. There 
was no significant difference in age between subject groups 
(P = 0.10). There was a highly significant difference in the 
gender distribution between the two groups (P = 0.0096). The 
proportion of males in the advanced group was higher than 
that in the moderate group (63.3% vs 40.5%).
A higher percentage of patients in the advanced group 
were older than 65 years. All six patients older than 80 years 
of age had advanced POAG. The OR of having advanced 
POAG between patients older or younger than 65 years was 
OR = 1.70 (0.90–3.25), which is not statistically significant.
Clinical findings are summarized in Table 3. Advanced 
patients had significantly higher mean IOP on initial presen-
tation in both eyes (OD: 30.93 vs 25.94 mmHg, P , 0.01; 
OS: 32.37 vs 26.42 mmHg, P , 0.01). The OR of being an 
advanced glaucoma patient with IOP $ 31 mmHg versus 
IOP # 30 mmHg was higher than for moderate patients (OR 
2.24, 95% CI 1.17–4.29). Increasing IOP also correlated with 
increasing CDR (Figure 1). Nearly 95% of patients with an 
IOP $ 40 mmHg had a CDR $ 0.7. This correlation was 
significant for men and women in both eyes (OD P = 0.01; 
OS P , 0.0001). Mean CDR was larger in advanced patients 
(0.85 vs 0.58, P , 0.001) and mean CDR asymmetry was 
also greater (0.14 vs 0.05, P , 0.001).
Table 2 Demographic characteristics of moderate and advanced 
primary open-angle glaucoma patients
Variable Advanced patients Moderate group
Patients 90 74
Age years, mean (SD) 
  ,35 
  35–49 
  50–64 
  65–79 
  $80
59.36 (14.81) 
6 
22 
23 
34 
6
55.53 (15.13) 
9 
13 
28 
23 
0
Gender
  Male
  Female
57/90 (63.3%) 
34/90 (36.7%)
30/74 (40.5%) 
43/74 (59.5%)
Abbreviation: SD, standard deviation.
Table 3 Comparison of clinical findings between the moderate 
and advanced primary open-angle glaucoma patients
Variable Advanced  
patients
Moderate  
group
P value
Patients 90 74
OD
  iOP mean (SD) 
  iOP . 30 (no) 
  iOP range 
  CDr
30.93 (13.65) 
35 
12–76 
0.84 (0.16)
25.94 (9.42) 
18 
10–60 
0.57 (0.14)
,0.01 
0.08 
 
,0.001
OS
  iOP mean (SD) 
  iOP . 30 (no) 
  iOP range 
  CDr
32.37 (13.69) 
39 
14–70 
0.85 (0.16)
26.42 (9.39) 
20 
10–65 
0.58 (0.14)
,0.01 
0.05 
 
,0.001
CDr asymmetry 0.14 (0.16) 0.05 (0.07) ,0.001
Abbreviations: OD, oculus dexter; IOP, intraocular pressure; CDR, cup-to-disk 
ratio; OS, oculus sinister.
Advanced patients had poorer visual acuity in both eyes 
(Table 4). There was no significant difference in the number 
of patients with 20/20 correctable vision for either group, 
however, more advanced patients met or exceeded World 
Health Organization (WHO) criteria for legal blindness 
(.20/200 VA) in at least one eye. When treating visual   acuities 
measured from the Snellen chart as ordinal data (20/20  
NLP) a difference was found in both eyes (OD P , 0.05; OS 
P , 0.05). Comparing VA converted to logMAR averages 
that excluded hand motion (HM), light perception (LP), and 
no light perception (NLP) for each eye showed a significant 
difference in OD (P , 0.05), but not in OS (P = 0.61). Poor 
vision was more often unilateral than bilateral: Less than 20% 
of advanced patients and only one moderate patient had VA 
. 20/200 oculi uterque (OU).
HVF results are summarized in Table 5. The MD value 
in the advanced glaucoma group was significantly worse 
than in the moderate group (−17.38 vs −6.69 dB, P , 0.001). 
The difference in PSD value between the moderate and 
advanced glaucoma group was not initially significant 
(6.71 vs 5.11 dB, P = 0.18) until adjusting for two outliers 
(P , 0.05). IOP in the advanced HVF group was signifi-
cantly higher than the moderate HVF group (36.46 vs 23.03 
mmHg, P , 0.001). CDR was also significantly higher in 
the advanced group versus the moderate group (0.83 vs 0.57, 
P , 0.001). Associations between HVF MD and PSD values 
with IOP, CDR, age, and VA are shown in Figures 2 and 3.
Discussion
This study compares two distinct primary open angle glau-
coma patient groups defined according to clinical disease 
severity for important associations between common risk 
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factors. Patient groups were defined according to modified 
ISGEO criteria and included a relatively equal number with 
no significant differences in age or ancestry.
Herndon et al identified in a previous outpatient survey 
of 198 glaucoma patients in Ghana that the most com-
mon form of glaucoma was primary open-angle glaucoma 
(44.2%)   followed by POAG suspects (30.5%) with chronic 
angle-closure glaucoma being rare (6.6%).6 Our study sought 
to compare associations between moderate and advanced 
POAG patients that closely resembled POAG and POAG 
suspect groups in that study. In choosing to define one group 
as having moderate glaucoma versus glaucoma suspects, 
we took into account that all patients in our study were 
receiving active glaucoma therapy and were being treated 
clinically as a continuum from moderate to severe disease. 
It is possible that a small group of “nonprogressers” were 
included in the moderate glaucoma group. Even so, it is 
not possible to isolate a group of  glaucoma suspects who 
are all nonprogressers either for comparison purposes with 
advanced patients. Using modified ISGEO classification 
is a reasonable alternative to define glaucoma patients 
with moderate stage disease at high risk for progression to 
advanced disease.
The mean age of glaucoma patients in our study was 
57.66 years which is similar to the average age in many 
other studies carried out in African populations.10 These 
include studies in St Lucia,11 Barbados,12 Tanzania,13 and 
South Africa.14 Direct comparisons with these population 
studies are difficult considering our smaller sample size and 
focus only on the outpatient clinical practice. While the vast 
majority of glaucoma patients that receive care do so in the 
outpatient setting, the vast majority of patients with glaucoma 
in Ghana are not receiving treatment so our findings cannot 
be applied to the population at large. We can conclude from 
our results that most cases of POAG at this outpatient site 
occur in patients older than 50 years of age.
Other studies, notably the early glaucoma manifest trial 
(EGMT), provide convincing evidence that POAG increases 
with age.15,16 The EGMT showed an increase in prevalence 
of POAG with age with less than 1% of patients ,65 years 
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Figure 1 Comparisons of cup-to-disk ratio as a function of age and intraocular pressure for moderate and advanced primary open angle patient groups. 
Notes: Overall CDR is slightly positively correlated with age among advanced patients, but the correlation was significant only in OD (P , 0.05). CDr strongly correlated 
with iOP. (A) The relationship between CDr OD and age (P , 0.05). (B) CDr OS and age (P = 0.32). (C) CDr and iOP OD (P = 0.01). (D) CDr and iOP OS (P , 0.0001).   
The linear relations between IOP/Age and CDR do not vary significantly by gender (P values for interaction between gender and slope .0.05). 
Abbreviations: CDR, cup-to-disk ratio; IOP, intraocular pressure; OD, oculus dexter; OS, oculus sinister.
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old affected, to approximately 1% at 70 years, and well 
over 3% at 75 years. The St Lucia and Barbados cohorts 
both showed a steady increase in age-associated prevalence. 
The major population study in Ghana reported that POAG 
affects 7.7% and 8.5% of people 30 and 40 years of age, 
  respectively.3 These figures are expected to increase as life 
expectancy increases in Ghana and will pose an increasing 
burden on eye care services in the outpatient setting.17
Elevated IOP is currently thought of as a major risk 
factor and no longer the defining characteristic of POAG.7 
There is some evidence to show cyclical fluctuations in 
IOP occur during a 24-hour day.18 Results are conflicting 
as to whether these fluctuations, measured in terms of the 
standard deviation for multiple office measures, lead to 
progression of POAG.19,20 For this study IOP was recorded 
as the average of two consecutive measurements taken from 
the patient chart prior to medical therapy. We feel that the 
accuracy of our definitions and findings were increased 
using this method.
In a previous case-control study in Ghana, glaucoma pro-
gression was determined to be most strongly correlated with 
IOP . 30 mmHg and a family history.5 Our study   supports 
this conclusion, however we can only draw associations from 
our findings without any temporal relationship between the 
two POAG groups. We further show a strong association 
between HVF MD values as independent predictors of POAG 
progression and pre-treatment IOP. MD greater than −12 dB 
is strongly associated with POAG stage and elevated IOP in 
this study.
Our study identified a significant difference in optic 
nerve asymmetry between the moderate and advanced 
glaucoma groups (P = 0.001) which indicates more severe 
unilateral optic neuropathy than bilateral optic neuropathy 
in these patients. It is not clear if this corresponds with our 
VA results which showed a significant difference in visual 
acuity between patient groups in OD only. What is clear is 
a high number of patients in the advanced POAG group met 
criteria for WHO blindness (VA . 20/200) which suggests 
the advanced POAG had affected central visual acuity more 
frequently in this patient group. Bilateral VA . 20/200 was 
uncommon. This appears to suggest VA is a poor predictor of 
early POAG progression, but a better predictor of late optic 
nerve damage. Wilson et al supported this finding by show-
ing evidence that the deterioration of visual acuity correlated 
with faster progression of POAG in black   populations.21 In 
comparisons of VA between groups, there was a discrep-
ancy in OS when compared as logMAR   integers. This is 
accounted for by the fact that a higher number of patients 
Table 4 Comparison of best corrected visual acuities between 
moderate and advanced open-angle glaucoma patients
Variable Advanced  
patients
Moderate  
group
P value
Patients 90 74
OD
Categorical analysis ,0.05
  20/20 
  20/25–20/60 
  20/70–20/160 
  20/200–20/2000 
  .20/2000 
  HM 
  NLP 
WHO blind
18 
28 
13 
7 
18 
3 
4 
32
15 
38 
5 
5 
9 
1 
1 
16
OS
Categorical analysis ,0.05
  20/20 
  20/25–20/60 
  20/70–20/160 
  20/200–20/2000 
  .20/2000 
  HM 
  NLP 
WHO blind
16 
35 
8 
4 
11 
9 
8 
32
14 
40 
6 
5 
8 
0 
1 
14
OU
  WHO blind OU 
  HM OU 
  NLP OU
15 
0 
0
1 
0 
0
Notes:  Comparisons  of  BCVA  results  showed  advanced  POAG  patients  had 
significantly poorer vision in OD (P , 0.05) and OS (P , 0.05). There was no 
significant difference in the number of patients with 20/20 correctable vision for 
either group, however, more advanced patients met or exceeded WHO criteria 
for legal blindness (.20/200 BCVA) in at least one eye. Poor vision was more often 
unilateral than bilateral. Less than 20% of advanced patients and only one moderate 
patient had BCVA . 20/200 OU. 
Abbreviations:  BCVA,  best  corrected  visual  acuity;  HM,  hand  motion;  NLP, 
no light perception; OD, oculus dexter; OS, oculus sinister; OU, oculi uterque; 
POAG, primary open-angle glaucoma; WHO, World Health Organization.
Table 5 Comparison of HVF test results between the moderate 
and advanced primary open-angle glaucoma patients
Variable Advanced  
patients
Moderate  
group
P value
Patients 19 19
Male/female 
MD mean (SD) 
PSD mean (SD) 
Age (years) 
iOP
13/6 
−17.38 (9.95) 
6.71 (4.62) 
53.89 (16.51) 
36.46 (12.40)
9/10 
−6.69 (5.38) 
5.11 (5.03) 
52.68 (14.30) 
23.03 (6.95)
0.32 
,0.001 
0.18* 
0.81 
,0.001
CDr 0.83 (0.20) 0.57 (0.15) ,0.001
Notes: Of 164 charts reviewed, 69 eyes of 38 patients had reliable HVF results. 
Of the 38 patients, 19 had advanced and 19 had moderate POAG. There was 
no significant difference in male/female distribution, VA, or age. The MD of the 
advanced HVF group was significantly more negative than the moderate HVF group 
(P , 0.001). *The difference in PSD between groups was not initially significant due 
to two outliers with PSD . 15 (P = 0.18), but became significant after adjusting for 
these data points (P , 0.05) (see Figure 3). 
Abbreviations:  VA,  visual  acuity;  IOP,  intraocular  pressure;  CDR,  cup-to-disk 
ratio;  HVF,  Humphrey  visual  field;  MD,  mean  deviation;  POAG,  primary 
open-angle glaucoma; PSD, pattern standard deviation.
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with HM, LP, or NLP in OS were omitted as these visual 
acuities do not correspond to a specific logMAR integer. 
Consequently the logMAR VA analysis result with miss-
ing information was less significant than the analysis using 
ordinal data.
Central corneal thickness is associated with IOP and 
progression of POAG.22,23 Corneas thinner than 520 µm 
display lower IOPs, whereas thicker corneas display higher 
IOPs. Pachymetry testing was not available at this clinic. 
Reduced central cornea thickness has been reported in Black 
populations.24 Pachymetry testing may have led to a further 
elevation of IOP results in this study.
We are the first to report in a West African population a 
strong positive predictive ratio between estimation of CDR 
and HVF MD and PSD results. A significant implication 
of this finding is that it encourages clinicians in Ghana to 
utilize automated perimetry testing as part of the standard 
glaucoma work up and provides a measure of assurance 
to clinicians unable to obtain a clear view of the optic 
nerve head due to a variety of factors or those treating 
POAG suspects who present with normal IOP. Although 
CDR is less diagnostic in comparison to newer imaging 
modalities such as ocular coherence tomography (OCT) 
and Heidelberg retinal tomography (HRT), it still has a 
role in identifying patients at risk for POAG progression in 
resource poor clinical settings, especially when combined 
with HVF automated perimetry and the identification of a 
clear optic nerve asymmetry. Obstacles to effective HVF 
testing include patient factors such as poor concentration, 
dementia, and other mental and physical problems as well 
as clinician factors such as the high cost of an automated 
threshold perimeter, time to achieve useful results, and 
training technicians to operate the device and gather reli-
able data.
A limitation of this study was incomplete records for 
HVF MD and PSD. Patient charts showed that more than 
80% of patients had HVF satisfactorily completed. HVF 
reports are given to the patient and copies were not consis-
tently made for the clinician records. All available results 
were reliable and unreliable results were repeated at the 
clinic’s expense. We acknowledge this reduced the power 
of our findings.
Conclusion
Comparisons of two POAG glaucoma groups at different 
stages of disease severity were undertaken to identify asso-
ciations between clinical findings. Significant differences 
were found between IOP, CDR, MD and PSD values. HVF 
is predictive of pretreated IOP, CDR, and severity of POAG 
and it is strongly encouraged as part of the standard glaucoma 
work up in all Ghanaian patients.
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